ASX [ADVANCED SEMICONDUCTOR ENGINEERING] 6-K: (Original Filing)
[Note: X Yes Not applicable]
[Note: X Yes Not applicable]
[Note: X Yes Not applicable]
[EXPLANATORYNOTE DESWELLINDUSTRIES,INC.NSOLIDATEDSTATEMENTOFCASHFLOWS(UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 Previously Effect of Filed Changejustedsh flows from operating activities : Netome $ 1,499 $ 1,499 $ 1,195justments to reconcile netome to netsh provided by operating activities :]
[EXPLANATORYNOTE DESWELLINDUSTRIES,INC.NSOLIDATEDSTATEMENTOFCASHFLOWS(UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 Previously Effect of Filed Changejustedsh flows from operating activities : Netome $ 1,499 $ 1,499 $ 1,195justments to reconcile netome to netsh provided by operating activities :]
[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]
[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]